Innovation Pharmaceuticals Inc (IPIX)

[frenchbroad]

Portfolio update today from Basilea Pharmaceutica says this:
"Furthermore, we have established ourselves as the partner of choice for companies seeking support in the development of their assets, with a focus on differentiation and commercial positioning."
And ends with this:
"Throughout 2024, we aim to continue expanding our R&D portfolio, through the identification of innovative, commercially attractive assets, addressing unmet medical needs in the treatment of severe fungal and bacterial diseases."
https://www.biospace.com/article/releases/basilea-provides-portfolio-status-update-jan-05-2024/

For my opinion Brilacidin can be a good fit with these objectives. We will see.
https://scholar.google.com/scholar?as_ylo=2020&q=brilacidin&hl=en&as_sdt=40007